Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01029392 · ClinicalTrials.gov registry record · Phase 3
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements
A Phase 3 study, sponsored by Corewell Health East.
- Completed
- Registry status
- Phase 3
- Development phase
- 75
- Enrollment target
NCT01029392: Completed Phase 3 study, sponsored by Corewell Health East.
NCT01029392 is a Phase 3 study that has completed, run by Corewell Health East. The registered enrollment target is 75 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01029392, a Phase 3 study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 75 participants
- Enrollment target
Study Summary
Our objective is to demonstrate that providing supplemental vitamin D to children with new onset DM will significantly decrease the levels of HbA1c and insulin requirement by the following methods. 1. Identify how often vitamin D levels are low in patients with new onset Type 1 diabetes mellitus (DM). 2. Record the hemoglobin A1c (HbA1c) level (which reflects the average blood sugar level over the past few months) and document insulin requirements before and after vitamin supplementation is given. Hypothesis: Maintaining vitamin D levels \>30 ng/ml will decrease HbA1c and insulin requirements.
Primary Outcome
Change in hemoglobin A1c calculated as a percentage change from baseline measurement
Interventions
- DRUG Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
What the finished NCT01029392 record still lists
NCT01029392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Vitamin D is the first listed.
NCT01029392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01029392 about?
NCT01029392 is a clinical study titled "Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements". Our objective is to demonstrate that providing supplemental vitamin D to children with new onset DM will significantly decrease the levels of HbA1c and insulin requirement by the following methods. 1. Identify how often vitamin D levels are low in patients with new onset Type 1 diabetes mellitus (D...
What is the current status of trial NCT01029392?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2009-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01029392?
The interventions under investigation include: Vitamin D (DRUG).
Who is sponsoring clinical trial NCT01029392?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01029392's enrollment target sits among peer trials
75 1773rd of 2000 higher than 221 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia